A lab system profiles several kinds of genetic test results in one run. ARCHIMED bought the business, now named Biomark Scientific.
ARCHIMED, a private equity firm, acquired Standard BioTools' Microfluidics Business, renaming it Biomark Scientific. The company specializes in automated genomic workflows and will operate independently under ARCHIMED. Standard BioTools (NASDAQ: LAB) completed the sale, focusing on its core life science tools business.
How this was made
The 30-second read
Why it matters
The deal finalizes the separation of the microfluidics platform, likely leading to a decline in LAB's share price while creating a standalone entity in the genomics market.
Market read
The acquisition removes a core segment from a listed life‑science tools company, likely prompting a sell‑off of its stock while reshaping the competitive landscape.
What to watch
Details on cash consideration or retained equity stakes were not disclosed, which could affect the net impact on LAB.
Background
ARCHIMED, a private‑equity firm focused on healthcare, acquired Standard BioTools' Microfluidics Business, rebranding it as Biomark Scientific.
Ticker impact
Standard BioTools (NASDAQ:LAB) completed its sale of the Microfluidics Business to ARCHIMED, making the unit independent as Biomark Scientific.
downward pressure as the market prices in the loss of the microfluidics segment
First report of the deal; no new cash amount disclosed, but the divestiture reduces future revenue potential.
Market effects
May pressure other life‑science tools companies as consolidation continues in the genomics equipment space.
US biotech and diagnostics sector could see modest re‑rating.
Limited to investors tracking US listed life‑science tool stocks.
Counterpoint
The spin‑off could unlock value for the new Biomark Scientific entity, potentially benefiting former shareholders if a future IPO is pursued.
Key entities
- private equity firmARCHIMED
Acquirer of Standard BioTools' Microfluidics Business.
- public companyStandard BioTools Inc.
Seller of its Microfluidics Business; ticker LAB.
- new standalone businessBiomark Scientific
Rebranded microfluidics unit focusing on genomic workflows.
